4//SEC Filing
Davis Thomas Andrew 4
Accession 0001457612-20-000031
CIK 0001457612other
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 4:18 PM ET
Size
7.2 KB
Accession
0001457612-20-000031
Insider Transaction Report
Form 4
Davis Thomas Andrew
CHIEF MEDICAL OFFICER
Transactions
- Award
Common Stock
2020-04-02+12,299→ 12,299 total - Award
Stock Option (Right to Buy)
2020-04-02+46,313→ 46,313 totalExercise: $1.66Exp: 2030-04-02→ Common Stock (46,313 underlying)
Footnotes (2)
- [F1]Represents restricted stock units granted to the Reporting Person under the Amended and Restated 2014 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest one-fourth (1/4) on each of the first four (4) anniversaries on the date of grant.
- [F2]The option will vest in 48 equal monthly installments beginning on the first monthly anniversary of the grant date.
Documents
Issuer
GENOCEA BIOSCIENCES, INC.
CIK 0001457612
Entity typeother
Related Parties
1- filerCIK 0001338185
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 4:18 PM ET
- Size
- 7.2 KB